Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis.
Transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves have been reported. This strategy avoids performing high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has not been described. We report a case of failing bioprosthetic tricuspid valve in a 48-year-old woman with carcinoid syndrome. We attempted a transatrial transcatheter approach and we successfully deployed a 26-mm Edwards Sapien balloon expandable bioprosthesis (Edwards Lifesciences, Irvine, CA) into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach. Therefore, tricuspid valve-in-valve implantation may be a viable treatment alternative in carefully selected patients.
Hon
Jimmy Kim Fatt
JK
Division of Cardiac Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Cheung
Anson
A
Ye
Jian
J
Carere
Ronald G
RG
Munt
Brad
B
Josan
Kiranbir
K
Lichtenstein
Samuel V
SV
Webb
John
J
D001705:Bioprosthesis; D006328:Cardiac Catheterization; D002404:Catheterization; D005260:Female; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D014261:Tricuspid Valve / Q000601:surgery*